Ronald C. Kennedy

Ronald C. Kennedy's AcademicInfluence.com Rankings

Ronald C. Kennedy

Biology

#7095

World Rank

#9955

Historical Rank

#2162

USA Rank

Immunology

#571

World Rank

#590

Historical Rank

#90

USA Rank

biology Degrees

Download Badge

Biology

Why Is Ronald C. Kennedy Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Ronald C. Kennedy was a virus immunologist at Texas Tech University. Prior to his appointment there he was affiliated with Baylor University, where he had previously done postdoctoral studies. Furthermore, when he switched affiliations to Texas Tech, he was also an adjunct, associate and full professor in the Departments of Microbiology and Pediatrics at the University of Texas Health Science Center at San Antonio. After his tenure in San Antonio, he switched affiliations to the University of Oklahoma Health Sciences Center's department of microbiology and immunology. In the 1980s he was affiliated with the Southwest Foundation for Biomedical Research, during which time he published some research pertaining to SV40 and intracellular protein transport. More recently, Kennedy has published some research regarding DNA vaccination, mostly in the journal Cancer Immunology, Immunotherapy.

(See a Problem?)

Ronald C. Kennedy's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Induction of nuclear transport with a synthetic peptide homologous to the SV40 T antigen transport signal (1986) (357)
Human immunodeficiency virus neutralizing antibodies recognize several conserved domains on the envelope glycoproteins (1987) (287)
Induction of anti‐HIV neutralizing antibodies by synthetic peptides. (1986) (216)
Characterization of PEDF: A multi‐functional serpin family protein (2009) (204)
Fetal immunization of baboons induces a fetal-specific antibody response (1999) (189)
Antiserum to a synthetic peptide recognizes the HTLV-III envelope glycoprotein. (1986) (161)
Anti-idiotypic antibody vaccine for type B viral hepatitis in chimpanzees. (1986) (151)
Neutralization of diverse HIV-1 strains by monoclonal antibodies raised against a gp41 synthetic peptide. (1988) (120)
Immune response to hepatitis B surface antigen: enhancement by prior injection of antibodies to the idiotype. (1983) (110)
Bacterial determinants of persistent throat colonization and the associated immune response in a primate model of human group A streptococcal pharyngeal infection (2000) (101)
Enhancement of the immune response to hepatitis B surface antigen. In vivo administration of antiidiotype induces anti-HBs that expresses a similar idiotype (1984) (100)
The sera of patients with Klebsiella infections contain a common anti-DNA idiotype (16/6) Id and anti-polynucleotide activity. (1987) (89)
Nonhuman primate models to evaluate vaccine safety and immunogenicity. (1997) (87)
HIV‐1 gp120 Proteins and gp160 Peptides Are Toxic to Brain Endothelial Cells and Neurons: Possible Pathway for HIV Entry into the Brain and HIV‐Associated Dementia (2002) (85)
Cutting Edge: Class I Presentation of Host Peptides Following HIV Infection1 (2003) (82)
A bactericidal antibody to Borrelia burgdorferi is directed against a variable region of the OspB protein (1994) (80)
Suppression of in vivo tumor formation induced by simian virus 40- transformed cells in mice receiving antiidiotypic antibodies (1985) (80)
Monoclonal anti-idiotypic antibody mimics the CD4 receptor and binds human immunodeficiency virus. (1987) (79)
Common idiotypic determinant associated with human antibodies to hepatitis B surface antigen. (1983) (78)
Comparison and Characterization of Immunoglobulin G Subclasses among Primate Species (1999) (75)
Induction of an anti-hepatitis B surface antigen response in mice by noninternal image (Ab2 alpha) anti-idiotypic antibodies. (1987) (75)
Adenovirus keratitis: a role for interleukin-8. (2000) (72)
Expression and immunogenicity of an 18-residue epitope of HIV1 gp41 inserted in the flagellar protein of a Salmonella live vaccine. (1995) (71)
Expression and characterization of hepatitis B virus surface antigen polypeptides in insect cells with a baculovirus expression system (1989) (69)
Mode of action of a lysostaphin-like bacteriolytic agent produced by Streptococcus zooepidemicus 4881 (1996) (68)
PEDF inhibits IL8 production in prostate cancer cells through PEDF receptor/phospholipase A2 and regulation of NFκB and PPARγ. (2011) (68)
Protection against a lethal challenge with SV40-transformed cells by the direct injection of DNA-encoding SV40 large tumor antigen. (1996) (67)
Comparative anatomy of mammalian conjunctival lymphoid tissue: a putative mucosal immune site. (1998) (66)
Current treatment options and biology of peritoneal mesothelioma: meeting summary of the first NIH peritoneal mesothelioma conference. (2006) (66)
NEUTRALISATION OF HIV ISOLATES BY ANTI-IDIOTYPIC ANTIBODIES WHICH MIMIC THE T4 (CD4) EPITOPE: A POTENTIAL AIDS VACCINE (1987) (64)
A common anti-DNA idiotype in sera of patients with active pulmonary tuberculosis. (1987) (64)
Synthetic peptides homologous to HIV transmembrane glycoprotein suppress normal human lymphocyte blastogenic response. (1988) (63)
Preclinical prophylactic efficacy testing of Sm-p80-based vaccine in a nonhuman primate model of Schistosoma mansoni infection and immunoglobulin G and E responses to Sm-p80 in human serum samples from an area where schistosomiasis is endemic. (2011) (62)
Antibody to hepatitis B virus induced by injecting antibodies to the idiotype. (1984) (62)
Anti-idiotypic antibodies: implications of internal image-based vaccines for infectious diseases. (1985) (61)
Possible role of anti-idiotypic antibodies in the induction of tumor immunity. (1987) (60)
Detection of interspecies idiotypic cross‐reactions associated with antibodies to hepatitis B surface antigen (1983) (58)
DNA vaccination strategies against infectious diseases. (1999) (58)
Isolation and characterization of simian immunodeficiency viruses from two subspecies of African green monkeys. (1990) (57)
Epitopes associated with a synthetic hepatitis B surface antigen peptide. (1983) (56)
Immunization of BALB/c mice with recombinant simian virus 40 large tumor antigen induces antibody-dependent cell-mediated cytotoxicity against simian virus 40-transformed cells. An antibody-based mechanism for tumor immunity. (1994) (56)
Regulation of capsule gene expression by group A Streptococcus during pharyngeal colonization and invasive infection (2001) (54)
Analysis of human lung endothelial cells for susceptibility to HIV type 1 infection, coreceptor expression, and cytotoxicity of gp120 protein. (2001) (53)
OspE-Related, OspF-Related, and Elp Lipoproteins Are Immunogenic in Baboons Experimentally Infected with Borrelia burgdorferi and in Human Lyme Disease Patients (2002) (51)
Genetic vaccines. (1999) (51)
Human mesotheliomas contain the simian virus-40 regulatory region and large tumor antigen DNA sequences. (1998) (50)
Nuclei number in human embryos co-cultured with human ampullary cells. (1996) (49)
Protective and antifecundity effects of Sm-p80-based DNA vaccine formulation against Schistosoma mansoni in a nonhuman primate model. (2009) (49)
A chemically defined liquid medium that supports primary isolation of Rochalimaea (Bartonella) henselae from blood and tissue specimens (1995) (48)
Antiidiotype modulation of herpes simplex virus infection leading to increased pathogenicity (1984) (48)
Anti-idiotypic antibodies as immunogens: idiotype-based vaccines. (1988) (48)
Inhibition of normal human natural killer cell activity by human immunodeficiency virus synthetic transmembrane peptides. (1988) (47)
DNA vaccines: Successes and limitations in cancer and infectious disease (2006) (47)
Experimental vaccines in animal models for schistosomiasis (2008) (47)
HIV-induced syncytia of a T cell line form single giant pseudopods and are motile. (1993) (46)
Resistance of previously infected chimpanzees to successive challenges with a heterologous intraclade B strain of human immunodeficiency virus type 1 (1996) (45)
Sm-p80-based DNA vaccine provides baboons with levels of protection against Schistosoma mansoni infection comparable to those achieved by the irradiated cercarial vaccine. (2010) (45)
Biotin-avidin-amplified enzyme immunoassay for detection of herpes simplex virus antigen in clinical specimens (1983) (45)
CD4+ T lymphocytes play a critical role in antibody production and tumor immunity against simian virus 40 large tumor antigen. (2003) (44)
Vaccines and Immunotherapeutics for the Treatment of Malignant Disease (2010) (43)
Use of a resin-bound synthetic peptide for identifying a neutralizing antigenic determinant associated with the human immunodeficiency virus envelope. (1987) (41)
Towards progress on DNA vaccines for cancer (2007) (41)
Maternal antibody transfer in baboons and mice vaccinated with a group B streptococcal polysaccharide conjugate. (2000) (40)
Immune response to human immunodeficiency virus. In vivo administration of anti-idiotype induces an anti-gp160 response specific for a synthetic peptide. (1987) (39)
T cell syncytia induced by HIV release. T cell chemoattractants: demonstration with a newly developed single cell chemotaxis chamber. (1998) (39)
Synthetic peptides corresponding to sequences in HIV envelope gp41 and gp120 enhance in vitro production of interleukin-1 and tumor necrosis factor but depress production of interferon-alpha, interferon-gamma and interleukin-2. (1991) (38)
SV40 Tag-specific cytotoxic T lymphocytes generated from the peripheral blood of malignant pleural mesothelioma patients (2002) (38)
Anti-idiotypes and immunity. (1986) (36)
Monoclonal anti-idiotypic antibodies induce humoral immune responses specific for simian virus 40 large tumor antigen in mice. (1990) (34)
Administration of noninternal image monoclonal anti-idiotypic antibodies induces idiotype-restricted responses specific for human immunodeficiency virus envelope glycoprotein epitopes. (1990) (33)
In-depth process understanding of RECOMBIVAX HB® maturation and potential epitope improvements with redox treatment: multifaceted biochemical and immunochemical characterization. (2011) (32)
A common human anti-hepatitis B surface antigen idiotype is associated with the group a conformation-dependent antigenic determinant. (1982) (31)
Characterization of anti-hepatitis B surface antigen monoclonal antibodies. (1983) (31)
The conjunctival lymphoid follicle in mucosal immunology. (2002) (31)
Immunogenicity of group B Streptococcus type III polysaccharide-tetanus toxoid vaccine in baboons (1996) (31)
Induction of antibodies to the human immunodeficiency virus type 1 by immunization of baboons with immunoglobulin molecules carrying the principal neutralizing determinant of the envelope protein. (1995) (30)
Characterization of the immune response to DNA vaccination strategies for schistosomiasis candidate antigen, Sm-p80 in the baboon. (2005) (30)
Autoantibodies and common idiotypes in men and women with sperm antibodies. (1988) (30)
A common anti-DNA idiotype and other autoantibodies in sera of offspring of mothers with systemic lupus erythematosus. (1987) (29)
Longitudinal analysis of the humoral immune response to human immunodeficiency virus type 1 (HIV-1) gp160 epitopes in rapidly progressing and nonprogressing HIV-1-infected subjects. (1993) (28)
Novel Kaposi's Sarcoma-Associated Herpesvirus Homolog in Baboons (2003) (28)
A NOD/SCID tumor model for human ovarian cancer that allows tracking of tumor progression through the biomarker Sp17. (2007) (28)
Inhibition of a common human anti-hepatitis B surface antigen idiotype by a cyclic synthetic peptide (1983) (28)
Application of a modified computer algorithm in determining potential antigenic determinants associated with the AIDS virus glycoprotein. (1985) (27)
Synthetic AIDS vaccine by targeting HIV receptor. (2002) (27)
Production and characterization of anti-idiotypic antibody reagents. (1989) (27)
Anatomy of mammalian conjunctival lymphoepithelium. (1998) (27)
Real time monitoring of antigenicity development of HBsAg virus-like particles (VLPs) during heat- and redox-treatment. (2011) (27)
Sequential Genital Infections by Herpes Simplex Viruses Types 1 and 2: Restriction Nuclease Analyses of Viruses from Recurrent Infections (1983) (27)
Synthetic peptides define the fine specificity of the human immunodeficiency virus (HIV) gp160 humoral immune response in HIV type 1-infected chimpanzees (1990) (26)
Comparison of humoral immune responses and tumor immunity in mice immunized with recombinant SV40 large tumor antigen and a monoclonal anti-idiotype. (1993) (26)
Synthesis of polyamide supports for use in peptide synthesis and as peptide-resin conjugates for antibody production. (2009) (26)
DNA vaccine strategies for the treatment of cancer. (1998) (26)
The baboon as a nonhuman primate model for assessing the effects of maternal immunization with Haemophilus influenzae type b polysaccharide vaccines (1997) (25)
Induction of antibodies to the envelope protein of the human immunodeficiency virus by immunization with monoclonal anti-idiotypes. (1991) (25)
Surrogate tumor antigen vaccination induces tumor-specific immunity and the rejection of spontaneous metastases. (2005) (24)
Characteristics of a shared idiotype by two IgM anti-herpes simplex virus monoclonal antibodies that recognize different determinants. (1983) (24)
Analysis of human endothelial cells and cortical neurons for susceptibility to HIV-1 infection and co-receptor expression. (2000) (24)
AIDS Research Reviews (1991) (23)
Induction of antibody response by DNA immunization of newborn baboons against influenza virus. (1999) (23)
Anti-idiotypic antibody response to monoclonal anti-CD4 preparations in nonhuman primate species. (1991) (23)
Is HIV involved in the pathogenesis of non-infectious pulmonary complications in infected patients? (2003) (23)
T cells and HIV‐induced T cell syncytia exhibit the same motility cycle (1995) (23)
Characterization of baboon class I major histocompatibility molecules. Implications for baboon-to-human xenotransplantation. (1996) (22)
Examination of sera from human immunodeficiency virus type 1 (HIV-1)-infected individuals for antibodies reactive with peptides corresponding to the principal neutralizing determinant of HIV-1 gp120 and for in vitro neutralizing activity (1992) (22)
Enhancement of viral hepatitis B antibody (Anti-HBs) response to a synthetic cyclic peptide by priming with anti-idiotype antibodies. (1984) (22)
Titration of a vaccine stock preparation of human immunodeficiency virus type 1SF2 in cultured lymphocytes and in chimpanzees. (1996) (22)
Activation of focal adhesion kinase in adenovirus-infected human corneal fibroblasts. (2002) (22)
Sperm Protein 17 is a Suitable Target for Adoptive T-cell–based Immunotherapy in Human Ovarian Cancer (2008) (22)
Idiotypes in medicine : autoimmunity, infection and cancer (1997) (21)
Common lupus anti-DNA antibody idiotypes in chronic liver diseases. (1987) (21)
Induction of immunological memory in baboons primed with DNA vaccine as neonates. (2001) (20)
Lack of genetic restriction by a potential anti-idiotype vaccine for type B viral hepatitis. (1986) (20)
Structural characterization of viral neutralizing monoclonal antibodies to hepatitis B surface antigen. (1998) (20)
Development of an experimental murine pulmonary metastasis model incorporating a viral encoded tumor specific antigen. (1997) (20)
Immunization of mice with baculovirus‐derived recombinant SV40 large tumour antigen induces protective tumour immunity to a lethal challenge with SV40‐transformed cells (1993) (20)
Comparison of simian virus 40 large T antigen recombinant protein and DNA immunization in the induction of protective immunity from experimental pulmonary metastasis (1999) (19)
Differential display to identify and isolate novel genes expressed during spermatogenesis. (1997) (19)
Evidence for and implications of SV40-like sequences in human mesotheliomas. (1996) (19)
Anti-idiotypes and their application under autoimmune, neoplastic, and infectious conditions. (1994) (19)
Quantitation of tumor foci in an experimental murine tumor model using computer-assisted video imaging. (1998) (18)
Humoral immune response in a marsupial Monodelphis domestica: Anti-isotypic and anti-idiotypic responses detected by species-specific monoclonal anti-immmunoglobulin reagentS (1995) (18)
A ROLE FOR ANTIBODIES IN TUMOR IMMUNITY (2003) (18)
Production and characterization of anti-idiotype reagents for the analysis of viral antigen systems. (1983) (17)
SV40 large tumor antigen associated synthetic peptides define native antigenic determinants and induce protective tumor immunity in mice. (1994) (17)
Anti-idiotypic antibodies: a new generation of vaccines against infectious agents. (1987) (16)
Cross-clade inhibition of human immunodeficiency virus type 1 primary isolates by monoclonal anti-CD4. (1998) (16)
In vitro simian virus 40 large tumor antigen expression correlates with differential immune responses following DNA immunization. (2005) (16)
SV40 association with human malignancies and mechanisms of tumor immunity by large tumor antigen (2007) (15)
Structural and cellular architecture of conjunctival lymphoid follicles in the baboon (Papio anubis). (2003) (15)
Idiotype networks in hepatitis B virus infections. (1985) (15)
The role of T cell motility and cytoskeletal reorganization in HIV-induced syncytium formation. (1994) (14)
Fcγ Receptors Play a Dominant Role in Protective Tumor Immunity against a Virus-Encoded Tumor-Specific Antigen in a Murine Model of Experimental Pulmonary Metastases (2006) (14)
Relation of the Escherichia coli dnaX gene to its two products-the τ and γ subunits of DNA polymerase III holoenzyme (1987) (14)
Nonhuman primates and their potential use in immunologically based investigations (1997) (14)
HIV-induced syncytia in peripheral blood cell cultures crawl by extending giant pseudopods. (1995) (14)
Structural characterization of a cross-reactive idiotype shared by monoclonal antibodies specific for the human CD4 molecule. (1991) (14)
DNA vaccination for HIV (1997) (14)
Nucleic Acid Vaccination against Virally Induced Tumors a (1995) (13)
Role of the Innate Immune Response and Tumor Immunity Associated with Simian Virus 40 Large Tumor Antigen (2010) (13)
Anti-idiotypic antibodies of a predefined specificity generated against CDR3VH synthetic peptides define a private anti-CD4 idiotype. (1990) (13)
Perspectives on developing anti-idiotype-based vaccines for controlling HIV infection. (1988) (13)
Patterns of antibody reactivity to selected human immunodeficiency virus type 1 (HIV-1) gp160 epitopes in infected individuals grouped according to CD4+ cell levels (2004) (12)
Immunotherapy of SV40 induced tumours in mice: a model for vaccine development. (1998) (12)
Idiotype cascades associated with the CD4-HIV glycoprotein 120 interaction: immunization with anti-idiotypic antibodies induces anti-anti-idiotypic responses with anti-CD4 specificity and in vitro neutralizing activity. (2000) (11)
Sequence comparisons of non-human primate HIV-1 coreceptor homologues. (1998) (11)
Inhibition of lymphokine-activated killer activity during HIV infection: role of HIV-1 gp41 synthetic peptides. (1990) (11)
Serologic crossreactions among primate immunoglobulins. (1995) (11)
Tumor Immunity against a Simian Virus 40 Oncoprotein Requires CD8+ T Lymphocytes in the Effector Immune Phase (2009) (11)
Characteristics of murine monoclonal anti-CD4. Epitope recognition, idiotype expression, and variable region gene sequence. (1992) (10)
Anti-idiotype vaccines in toxicology (1992) (10)
Molecular characterization and structural modeling of immunoglobulin variable regions from murine monoclonal antibodies specific for hepatitis B virus surface antigen. (1993) (9)
Lymphocyte subsets in chimpanzees. (1988) (9)
Fine specificity of the murine immune response to SV40 large tumour antigen utilizing synthetic peptides that define selected epitopes (1994) (9)
Analysis of nonhuman primate peripheral blood mononuclear cells for susceptibility to HIV-1 infection and HIV coreceptor expression. (1999) (9)
Anti-idiotypic antibodies as idiotope vaccines that induce immunity against infectious agents. (1986) (9)
Immunoglobulin idiotypes: analysis of viral antigen-antibody systems. (1985) (9)
Comparison of the murine humoral immune response to recombinant simian virus 40 large tumor antigen: Epitope specificity and idiotype expression (1993) (9)
Anti-peptide reagent identifies a primary-structure-dependent, cross-reactive idiotype expressed on heavy and light chains from a murine monoclonal anti-CD4. (1993) (9)
Folding patterns of immunoglobulin molecules identified by urea gradient electrophoresis. (1994) (9)
Comparison of nonhuman primate antibodies against Haemophilus influenzae type b polysaccharide with human antibodies in oligoclonality and in vivo protective potency (1994) (9)
Fine specificity of the murine antibody response to HIV-1 gp160 determined by synthetic peptides which define selected epitopes. (1992) (9)
DNA cancer vaccination strategies target SV40 large tumour antigen in a murine experimental metastasis model. (2000) (9)
Infection of baboon microglia with SIV-HIV recombinant viruses: role of CD4 and chemokine receptors. (2002) (9)
Phagocytosis of individual CD4+ T cells by HIV-induced T cell syncytia. (1995) (8)
Methods for generating reagents to examine idiotype networks within antiviral immune responses. (1989) (8)
Purification and characterization of secretory IgA from baboon colostrum. (1997) (7)
Adjuvanticity of stearyl tyrosine on the antibody response to peptide 503-535 from HIV gp160. (1992) (7)
Humoral immune response in a marsupial Monodelphis domestica: anti-isotypic and anti-idiotypic responses detected by species-specific monoclonal anti-immunoglobulin reagents. (1995) (7)
Human immunodeficiency virus gp120 glycoprotein detected by a monoclonal antibody to a synthetic peptide (1986) (7)
The detection of a common idiotype of anti-DNA antibodies in the sera of patients with monoclonal gammopathies (1986) (7)
Evidence of simian virus 40 exposure in a colony of captive baboons. (2008) (7)
Immunoglobulin variable regions as idiotype vaccines. (1999) (6)
CD4+ T Lymphocytes Are Critical Mediators of Tumor Immunity to Simian Virus 40 Large Tumor Antigen Induced by Vaccination with Plasmid DNA (2011) (6)
DNA vaccines - from principle to practice (1997) (6)
Increased presence of common systemic lupus erythematosus (SLE) anti-DNA idiotypes (16/6 Id, 32/15 Id) is induced by procainamide (1987) (6)
Progress on the development of universal influenza vaccines. (2011) (6)
Monoclonal antibody testing (2006) (6)
Molecular Characterization of Immunoglobulin Variable Regio from Murine Monoclonal Antibodies Specific for Simian Virus 40 Large Tumour Antigen (1994) (5)
Measles virus infection and vaccination: potential role in chronic illness and associated adverse events. (2004) (5)
Production and characterization of murine monoclonal antibodies specific for baboon IgG heavy and light chain epitopes (1994) (5)
Immunogenicity of hepatitis B surface antigen derived from the baculovirus expression vector system: a mouse potency study. (1991) (5)
Characterization of private and cross-reactive idiotypes associated with human antibodies to hepatitis B surface antigen. (1992) (5)
Concepts of idiotype-based vaccines for hepatitis B virus and human immunodeficiency virus. (1990) (5)
Innate Immunity in the Cornea: A Putative Role for Keratocytes in the Chemokine Response to Viral Infection of the Human Corneal Stroma (2002) (5)
Relation of the Escherichia coli dnaX gene to its two products--the tau and gamma subunits of DNA polymerase III holoenzyme. (1987) (5)
Antibody reactivity to synthetic peptides representing the principal neutralizing determinant of HIV-1 in mouse strains following repeated immunization with recombinant gp160. (1993) (4)
Neutralizing antibody induced in mice by novel glycoconjugates of human immunodeficiency virus type 1 gp120 and env2-3. (2002) (4)
Sequence analysis of the variable region of a mouse gene encoding a monoclonal anti-idiotypic antibody that detects a restricted idiotype on anti-HIV-1 gp160. (1991) (4)
Anti-idiotype responses abrogate anti-CD4–induced tolerance to a tumor-specific antigen and promote systemic tumor immunity (2004) (4)
Synthetic hepatitis B surface antigen peptide vaccine. (1985) (4)
Idiotype network components are involved in the murine immune response to simian virus 40 large tumor antigen (2005) (4)
Idiotypic cascades associated with the CD4-HIV gp120 interaction: principles for idiotype-based vaccines. (1990) (4)
Fine specificity of the humoral immune response to HIV‐1 GP160 in HIV‐1 infected individuals from tanzania (1992) (3)
In vivo detection of human hepatoma secreting hepatitis B surface antigen in nude mice with radiolabeled monoclonal antibodies that recognize distinct epitopes. (1985) (3)
Anti-idiotype modulation of the in vitro immune response to hepatitis B surface antigen (HBsAg) following remote infection by hepatitis B virus in man. (1989) (3)
The Impact of Idiotype-Based Strategies on Cancer Immunity (1991) (3)
Strategies for developing vaccines against acquired immunodeficiency syndrome. (1989) (3)
Further Characterization of Internal Image‐Bearing Anti‐Idiotypic Antibodies: Specific Binding to Immunoglobulin Receptors on Murine Hybridoma Cells Secreting Antibodies to Hepatitis B Surface Antigen. (1986) (3)
Anti-idiotype antibodies and immunization against infectious diseases (1988) (3)
ANTI-HEPATITIS B SURFACE ANTIGEN IDIOTYPE (1985) (3)
Inhibition of prostate carcinogenesis by combined active immunoprophylaxis (2007) (3)
Hepatitis B Surface Antigen Polypeptide and Synthetic Peptide Vaccines (1984) (2)
Allocation of cells to trophectoderm and inner cell mass in mouse and human embryos co-cultured with epithelial and fibroblast cell lines (1998) (2)
Examination of lymphokines induced in mice following immunization with recombinant simian virus 40 large tumor antigen (1995) (2)
Presence of neutralizing antibodies to heterologous human immunodeficiency virus type 1 isolates in sera of infected individuals is not predictive of rate of disease progression (1995) (2)
Active immunization strategies using anti-idiotypic antibodies. (1992) (2)
Introduction: Concepts in Developing an AIDS Vaccine (1990) (1)
The role of gamma interferon in DNA vaccine-induced tumor immunity targeting simian virus 40 large tumor antigen (2013) (1)
Anti-Idiotypic Antibodies as Potential Viral Vaccines (1991) (1)
Antigen mimicry by anti-idiotype antibodies that recognize a common anti-hepatitis B surface antigen idiotype. (1985) (1)
CD 4 T Lymphocytes Play a Critical Role in Antibody Production and Tumor Immunity against Simian Virus 40 Large Tumor Antigen 1 (2003) (1)
Adjuvanticity of stearyl tyrosine on the antibody response to peptide 503-535 from HIV gp160. (1992) (1)
Overview on the use of synthetic peptides in human immunodeficiency virus infection. (1988) (1)
Characteristics of Monoclonal Antibodies to Herpes Simplex Type 2 (1983) (1)
DNA Vaccines as Cancer Treatment Modalities (2003) (1)
Strutural correlates of immunoglobulin variable region antigenic determinants (1992) (1)
Use of Anti-Idiotypes and Synthetic Peptides for Control of Human T- Lymphotropic Virus Type 3 Infections (1988) (0)
Erratum: Letter to the Editor: Monoclonal antibody testing (Journal of Medicine Primatology (2006) vol. 35 (405) (2007) (0)
F.125. Systemic Tumor Immunity Requires Distinctive Immune Responses Between CD4+ and CD8+ T Lymphocytes Against a Tumor Specific Antigen (2006) (0)
Idiotypes and anti-idiotypes: an update in potential applications for developing an AIDS vaccine. (1991) (0)
Tumor Immunity against a Simian Virus 40 Oncoprotein Requires CD8 (cid:1) T Lymphocytes in the Effector Immune Phase (cid:1) (2009) (0)
Pathogen-derived MHC class I ligand identification in HIV-1 infected cells (2001) (0)
Thesera ofpatients withKlebsiella infections contain a commonanti-DNA idiotype (16/6) Idandanti-polynucleot ide activity (1987) (0)
Genetic immunization as a novel means for inducing protective immunity (1998) (0)
Immunity to Bacteria (2007) (0)
domains on the envelope glycoproteins. antibodies recognize several conserved Human immunodeficiency virus neutralizing (2013) (0)
Detection of human acid alpha-glucosidase in fibroblasts using monoclonal antibodies in a biotin-avidin amplified ELISA. (1985) (0)
Immunological Approach to the Identification and Development of Vaccines to Various Toxins (1990) (0)
Comparison of the mouse antibody response to different antigenic formulations incorporating a synthetic peptide representing the heavy chain second complementarity-determining region of a mouse monoclonal anti-CD4 antibody. (1992) (0)
Monoclonal anti-idiotypic antibody mimics the CD 4 receptor and binds human immunodeficiency virus ( acquired immunodeficiency syndrome / receptor mimicry / T-lymphocyte surface molecule ) (2017) (0)
Erratum (2007) (0)
Deleted In Cancer 1 (DICE1): Search for a function in prostate carcinoma (PCa) (2007) (0)
Use of Synthetic Peptides and Anti-Idiotypes for Controlling Human Immunodeficiency Virus Infection (1991) (0)
HBV vaccines without HBsAg: Immune mimicry via antiidiotype antibodies (1986) (0)
Monoclonal immunoglobulin m antibodies and methods for their preparation. (1983) (0)
The placental transfer of maternal immunoglobulins in the baboon (1997) (0)
Production of antibody to hepatitis B using only antibodies that are directed against anti-hepatitis B antibodies (1984) (0)
Innate immunity in th e cornea: a putative role for keratocytes in the chemokine response to viral infection of the human corneal stroma. (2000) (0)
Modification of herpes simplex virus pathogenicity in mice by injection of anti idiotype antibodies (1984) (0)
Peptides Following HIV Infection Cutting Edge: Class I Presentation of Host (2013) (0)
Synthetic peptides identify a critical lysine residue in the SV-40 nuclear transport signal (1988) (0)
Immunologic mechanisms against an SV40 viral oncoprotein require humoral and cell-mediated pathways to achieve tumor immunity (40.25) (2009) (0)
Exhaled nitric oxide (eNO) in asthma: Variability and relation to asthma severity, treatment, and lymphocyte activation☆ (2004) (0)
tumourantigen induces protective tumourimmunitytoa lethal challenge with SV40-transformed cells (1993) (0)
High-technology route to virus vaccines : proceedings of the First Annual Southwest Foundation for Biomedical Research International Symposium, Houston, Texas, 8-10 November 1984 (1985) (0)
Modulation of the Immune Response to Simian Virus 40 Large Tumor Antigen Via Idiotype–Anti-Idiotype Interactions (1997) (0)
CD4 (cid:1) T Lymphocytes Are Critical Mediators of Tumor Immunity to Simian Virus 40 Large Tumor Antigen Induced by Vaccination with Plasmid DNA (cid:1) (2011) (0)

This paper list is powered by the following services:

Other Resources About Ronald C. Kennedy

en.wikipedia.org

What Schools Are Affiliated With Ronald C. Kennedy?

Ronald C. Kennedy is affiliated with the following schools: